| SCHEDULE OF ANTI DILUTIVE SECURITIES |
The
following potentially dilutive securities were excluded from the calculation of diluted net loss per share because the effects were anti-dilutive
based on the application of the treasury stock method and because the Company incurred net losses during the period:
SCHEDULE
OF ANTI DILUTIVE SECURITIES
| |
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
For
the Six Months Ended June 30, |
|
|
For
the Three Months Ended June 30, |
|
| |
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
| Convertible
notes payable |
|
|
18,194,940 |
|
|
|
6,644,940 |
|
|
|
18,194,940 |
|
|
|
6,644,940 |
|
| Restricted
stock units |
|
|
343,512 |
|
|
|
- |
|
|
|
171,756 |
|
|
|
11,840,890 |
|
Warrants
to purchase shares
of common stock |
|
|
- |
|
|
|
8,432,288 |
|
|
|
- |
|
|
|
11,840,890 |
|
| Total
potentially dilutive shares |
|
|
18,538,452 |
|
|
|
15,077,228 |
|
|
|
18,366,696 |
|
|
|
18,485,830 |
|
|
The
following potentially dilutive securities were excluded from the calculation of diluted net loss per share because the effects were anti-dilutive
based on the application of the treasury stock method and because the Company incurred net losses during the period:
SCHEDULE
OF ANTI DILUTIVE SECURITIES
| |
|
2022 |
|
|
2021 |
|
| |
|
For the Years Ended December 31, |
|
| |
|
2022 |
|
|
2021 |
|
| Convertible notes payable |
|
|
11,726,940 |
|
|
|
5,489,940 |
|
| Warrants to purchase shares of common stock |
|
|
15,192,493 |
|
|
|
7,992,558 |
|
| Total potentially dilutive shares |
|
|
26,919,433 |
|
|
|
13,482,498 |
|
|
| SCHEDULE OF COMPUTATION OF BASIC AND DILUTED NET INCOME PER SHARE |
The
following table sets forth the computation of basic and diluted net income per share:
SCHEDULE OF COMPUTATION OF BASIC AND DILUTED NET INCOME PER SHARE
| |
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Six Months Ended June 30, |
|
|
Three Months Ended June 30, |
|
| |
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| Net loss attributable to the common stockholders |
|
$ |
(2,064,160 |
) |
|
$ |
(1,344,371 |
) |
|
$ |
(723,124 |
) |
|
$ |
(666,325 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Basic weighted average outstanding shares of common stock |
|
|
40,911,801 |
|
|
|
37,295,813 |
|
|
|
43,331,086 |
|
|
|
37,295,813 |
|
| Dilutive effect of options and warrants |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
| Diluted weighted average common stock and common stock equivalents |
|
|
40,911,801 |
|
|
|
37,295,813 |
|
|
|
43,331,086 |
|
|
|
37,295,813 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Loss per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Basic and diluted |
|
$ |
(0.05 |
) |
|
$ |
(0.04 |
) |
|
$ |
(0.02 |
) |
|
$ |
(0.02 |
) |
| Earnings per share, Basic |
|
$ |
(0.05 |
) |
|
$ |
(0.04 |
) |
|
$ |
(0.02 |
) |
|
$ |
(0.02 |
) |
|
The
following table sets forth the computation of basic and diluted net income per share:
SCHEDULE OF COMPUTATION OF BASIC AND DILUTED NET INCOME PER SHARE
| |
|
2022 |
|
|
2021 |
|
| |
|
Years Ended December 31, |
|
| |
|
2022 |
|
|
2021 |
|
| |
|
|
|
|
|
|
| Net loss attributable to the common stockholders |
|
$ |
(2,929,817 |
) |
|
$ |
(3,004,619 |
) |
| |
|
|
|
|
|
|
|
|
| Basic weighted average outstanding shares of common stock |
|
|
37,396,591 |
|
|
|
36,396,594 |
|
| Dilutive effect of options and warrants |
|
|
- |
|
|
|
- |
|
| Diluted weighted average common stock and common stock equivalents |
|
|
37,396,591 |
|
|
|
36,396,594 |
|
| |
|
|
|
|
|
|
|
|
| Loss per share: |
|
|
|
|
|
|
|
|
| Basic and diluted |
|
$ |
(0.08 |
) |
|
$ |
(0.08 |
) |
|